Latest Distributions News

Orthocell has lodged a regulatory application to distribute its nerve repair product Remplir™ across the EU and UK, aiming to tap into a $750 million market with approval expected by Q3 2026.

Neuren Pharmaceuticals’ partner Acadia secures FDA approval for DAYBUE STIX, a new powder formulation of trofinetide offering greater flexibility for Rett syndrome patients. This milestone expands treatment options and sets the stage for increased royalty revenue in 2026.

DigiCo Infrastructure REIT has announced a 6.0 cents per security distribution for the half-year ending December 2025, reflecting steady income from its expanding data centre portfolio.

Redcastle Resources reports exceptional high-grade gold assay results from initial grade control drilling at Redcastle Reef, including a standout intercept of 1m at 3,650 g/t Au. These findings reinforce the continuity of high-grade mineralisation and underpin ongoing mine planning efforts.

Echo IQ has formally lodged its FDA 510(k) submission for EchoSolv HF, an AI-driven heart failure diagnostic software validated by Mayo Clinic data, aiming to tap into a $60 billion US market.

Metal Bank Limited addresses ASX concerns over recent share price volatility, confirming a pending Mineral Resource Estimate announcement and recent strategic moves as key drivers.

Goodman Group has announced an estimated ordinary dividend of AUD 0.15 per security for the six months ending December 2025, with payment scheduled for February 2026. The dividend is unfranked, and final details will be confirmed in February.

APC Minerals has launched a pro-rata entitlement offer to raise up to $1.38 million by issuing new shares to existing shareholders. Letters detailing the offer have now been dispatched, with documents accessible electronically.

HomeCo Daily Needs REIT has announced an ordinary unfranked quarterly distribution of AUD 0.0215 per unit for the period ending 31 December 2025, with a Dividend Reinvestment Plan available to investors.

APC Minerals Limited has announced a renounceable pro-rata entitlement offer to raise approximately $1.38 million, issuing 13 new shares for every 11 held at $0.004 each. Overseas shareholders are excluded but will have their entitlements sold by a nominee.

Charter Hall Long WALE REIT has announced an ordinary unfranked quarterly distribution of AUD 0.06375 per security, payable in February 2026, alongside a Dividend Reinvestment Plan offering a 1% discount.

Acrux Limited has sold the US registration and distribution rights for its Prilocaine 2.5% and Lidocaine 2.5% cream for US$550,000, redirecting resources towards its growing Hormone Replacement Therapy portfolio.